Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 151.00
-4.50 (-2.89%)
Feb 21, 2025, 1:30 PM CST
Alar Pharmaceuticals Revenue
Alar Pharmaceuticals had revenue of 5.82M TWD in the quarter ending September 30, 2024, with 627.13% growth. This brings the company's revenue in the last twelve months to 474.29M, up 29,543.06% year-over-year. In the year 2023, Alar Pharmaceuticals had annual revenue of 469.27M with 58,559.00% growth.
Revenue (ttm)
474.29M
Revenue Growth
+29,543.06%
P/S Ratio
20.30
Revenue / Employee
21.56M
Employees
22
Market Cap
10.09B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |